Effect of early dose increase of evocalcet for intractable hypercalcemia caused by parathyroid carcinoma

SUMMARY: Hypercalcemia due to parathyroid carcinoma (PC) is safely and quickly controlled with rapidly increasing evocalcet doses. Most parathyroid carcinomas are detected because of hypercalcemia due to primary hyperparathyroidism (PHPT). Hypercalcemia becomes more severe in patients with PC than t...

Descripción completa

Detalles Bibliográficos
Autores principales: Morishita, Azusa, Hozumi, Yasuo, Ishii, Hiroaki, Hokazono, Yukio, Manuel Yosei Kikuchi, Clovis, Shimasaki, Megumi, Itaya, Mikiko, Oura, Masaharu, Kuriki, Ken, Hishida, Akira, Seki, George
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2022
Materias:
Novel Treatment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875064/
https://www.ncbi.nlm.nih.gov/pubmed/36602916
http://dx.doi.org/10.1530/EDM-22-0269

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875064/
https://www.ncbi.nlm.nih.gov/pubmed/36602916
http://dx.doi.org/10.1530/EDM-22-0269

Ejemplares similares